Adarx Pharmaceuticals, Inc.
Clinical trials sponsored by Adarx Pharmaceuticals, Inc., explained in plain language.
-
New blood pressure drug enters first human testing
Disease control OngoingThis is an early safety study testing a new drug called ADX-850 in 28 people with mild to moderate high blood pressure. The main goal is to see how safe the drug is and how the body processes it. Researchers will also check if it affects blood pressure levels.
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
First human tests begin for new swelling disorder drug
Disease control OngoingThis early-stage study is testing a new drug called ADX-324 to see if it's safe for people. First, healthy volunteers receive different doses. Then, a small group of patients with hereditary angioedema—a rare condition causing sudden, severe swelling—will try it. The main goal is…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for PNH patients battling anemia
Disease control OngoingThis early-stage study is testing a new drug called ADX-038. First, it checks for safety in healthy volunteers. Then, it will be given to a small group of people with PNH who still have anemia despite being on their current standard medication. The main goal is to see if the drug…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC